Skip to main content
. 2013 Feb 12;108(4):951–958. doi: 10.1038/bjc.2013.47

Table 3. GNAS and KRAS mutations in mucinous tumours of diverse organs.

 
 
  GNAS KRAS
Site Histology N Total mutated n Nucleotide Amino acid Total mutated n Nucleotide Amino acid
Appendix
Low-grade appendiceal mucinous neoplasm
32
16 (50%)
1
c.601C>A
p.R201S
30 (94%)
1
c.34G>T
p.G12C
 
 
 
 
6
c.601C>T
p.R201C
 
13
c.35G>A
p.G12D
 
 
 
 
7
c.602G>A
p.R201H
 
1
c.35G>C
p.G12A
 
 
 
 
2
c.601C>T, c.602G>A
p.R201C, p.R201H
 
11
c.35G>T
p.G12V
 
 
 
 
 
 
 
 
4
c.38G>A
p.G13D
 
Mucinous adenocarcinoma
3
0
 
 
 
3 (100%)
1
c.34G>A
p.G12S
 
 
 
 
 
 
 
 
2
c.35G>A
p.G12D
Colorectum
Mucinous adenocarcinoma
33
3 (9%)
1
c.601C>T
p.R201C
9 (27%)
4
c.35G>A
p.G12D
 
 
 
 
2
c.602G>A
p.R201H
 
4
c.35G>T
p.G12V
 
 
 
 
 
 
 
 
1
c.38G>A
p.G13D
Ovary
Mucinous cystadenoma
23
2 (9%)
1
c.602G>A
p.R201H
7 (30%)
2
c.35G>A
p.G12D
 
 
 
 
1
c.601C>T, c.602G>A
p.R201C, p.R201H
 
5
c.35G>T
p.G12V
 
Mucinous borderline tumour
24
0
 
 
 
21 (88%)
1
c.34G>C
p.G12R
 
 
 
 
 
 
 
 
11
c.35G>A
p.G12D
 
 
 
 
 
 
 
 
8
c.35G>T
p.G12V
 
 
 
 
 
 
 
 
1
c.37G>T
p.G13C
 
Mucinous cystadenocarcinoma
15
0
 
 
 
8 (53%)
1
c.34G>C
p.G12R
 
 
 
 
 
 
 
 
2
c.35G>A
p.G12D
 
 
 
 
 
 
 
 
5
c.35G>T
p.G12V
Pancreas
Intraductal papillary mucinous neoplasm
37
30 (81%)
1
c.601C>A
p.R201S
25 (68%)
1
c.34G>A
p.G12S
 
 
 
 
15
c.601C>T
p.R201C
 
3
c.34G>C
p.G12R
 
 
 
 
12
c.602G>A
p.R201H
 
7
c.35G>A
p.G12D
 
 
 
 
2
c.601C>T, c.602G>A
p.R201C, p.R201H
 
13
c.35G>T
p.G12V
 
 
 
 
 
 
 
 
1
c.38G>A
p.G13D
Lung
Mucinous adenocarcinomaa
18
0
 
 
 
14 (78%)
2
c.34G>T
p.G12C
 
 
 
 
 
 
 
 
7
c.35G>A
p.G12D
 
 
 
 
 
 
 
 
5
c.35G>T
p.G12V
Breast Mucinous adenocarcinoma 36 0       0      

N, total number of examined lesions; n, lesions with each mutation.

a

Formerly mucinous-bronchioloalveolar carcinoma.